December 9, 2002
Apotex Granted Approvable Letter for Gabapentin Capsules
WESTON, FLORIDA, U.S.A. – Apotex Corp. today announced it has received an Approvable Letter from the U.S. Food and Drug Administration (FDA) for its gabapentin capsules. Upon final FDA approval, Apotex’ gabapentin capsules will be considered AB-rated to Neurontin® Capsules from Pfizer.

December 4, 2002
Apotex Donates $3 Million to Université De Montréal's Faculty of Pharmacy
MONTRÉAL, QUÉBEC, CANADA – Generic pharmaceutical manufacturer Apotex today announced that it is donating $3 million to the Université de Montréal’s Faculty of Pharmacy. The donation will enhance training of new pharmacists, and will help advance the profession in their support of the healthcare system in Quebec. This is the largest private donation, for training purposes, received by the Faculty of Pharmacy...

September 3, 2002
To Fill 400 Job Openings Company Targets Competitors’ Employees On Their Way to Work
TORONTO, ONTARIO, CANADA – Today, The Apotex Group is launching a creative billboard campaign across the Greater Toronto Area to try to fill 400 job openings. These billboards are strategically placed near the competitors’ facilities...

August 6, 2002
Largest Canadian Pharmaceutical Fine Chemical Company Announces Major Expansions in Brantford
BRANTFORD, ONTARIO, CANADA – Brantford Chemicals (BCI) a member of the Apotex Group of Pharmaceutical Companies announced today the opening of the first phase of a two-part expansion with a total investment value of $22 million. This expansion will create approximately 90 new jobs of which 60 have already been filled in the Brantford area...

June 12, 2002
Hundreds of New Pharmaceutical Jobs: Kitchener-Waterloo Open House To Target Technical Professionals
TORONTO, ONTARIO, CANADA – The Apotex Group of Pharmaceutical Companies is continuing its year long hiring of new employees. The organization needs to fill 400 positions immediately and a further 500 to 600 in the next 12 to 18 months...